Endpoint definition
↥| Name | Q17_EPIDERMOL_BULLOSA |
|---|---|
| Long name | Epidermolysis bullosa |
| Hospital Discharge registry | ICD-10: Q81 |
| Cause of Death registry | ICD-10: Q81 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF4 |
| Latin name | Epidermolysis bullosa |
Epidermolysis bullosa
epidermolysis bullosa: a group of inherited connective tissue diseases that cause blisters in the skin and mucosal membranes, with an incidence of 20 per million newborns in the United States.It is a result of a defect in anchoring between the epidermis and dermis, resulting in friction and skin fragility. Its severity ranges from mild to lethal.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 15 | 10 | - |
| Unadjusted prevalence (%) | 0.01 | 0.01 | - |
| Mean age at first event (years) | 31.69 | 38.51 | - |
| Case fatality at 5-years (%) | 0.00 | 0.00 | - |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.0 | 2.0 | - |
| Recurrence at 6 months (%) | 40.00 | 40.00 | - |
Survival analyses between endpoints
↥Plot
before Epidermolysis bullosa
after Epidermolysis bullosa
Loading survival analyses plot…
Table
Loading survival analyses table…